Kura Oncology, Inc. KURA
Updated: 9 Aug 2026
No signal published yet
We already track Kura Oncology and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Kura Oncology, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Kura Oncology free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 5, 2026, Kura Oncology announced that it will report its second quarter 2026 financial results on August 12, 2026. Previously on May 12, 2026, the company reported first-quarter 2026 net product revenue of $5.8 million for Komzifti in its first full quarter of commercial availability. Total cash, cash equivalents, and short-term investments stood at $580.8 million as of March 31, 2026.
What Firelda Watch includes for Kura Oncology, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Kura Oncology, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Kura Oncology free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more